BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma

NCT06644443 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse

Interventions

BIOLOGICAL: BCMA-GPRC5D CAR-T cells

Sponsor

Shenzhen University General Hospital